| Trial name or title |
Femoroacetabular Impingement Randomized Controlled Trial (FIRST) |
| Methods |
Randomised double blind parallel efficacy trial |
| Participants |
Inclusion criteria:
Hip pain for greater than 6 months with no relief from non‐operative means CAM or mixed‐type FAI as diagnosed on x‐rays and MRI/MRA Temporary relief from an intra‐articular hip injection Informed consent from participant English speaker
Exclusion criteria:
Inability to complete forms or follow up due to cognitive or language barriers Previous randomisation in a study involving FAI Evidence of hip dysplasia (centre edge angle less than 20) Presence of advanced hip osteoarthritis (Tonnis Grade 3 or 4) Previous trauma to the affected hip previous surgery on the affected hip Isolated pincer lesion Immunosuppressive medication use Chronic pain syndromes Significant medical co‐morbidities (requiring daily assistance for activities of daily living (ADLs)) History of paediatric hip disease (Legg‐Calve‐Perthes, slipped capital femoral epiphysis) Ongoing litigation or compensation claims secondary to hip
|
| Interventions |
|
| Outcomes |
Primary outcome measures:
Feasibility of definitive trial (time frame: 2 years)
Secondary outcome measures:
Change in pain scores at 6 months using visual rating scale (time frame: 6 months)
Change in heath status and function using SF‐12, NAHS and HOS questionnaires (time frame: 1 year) |
| Starting date |
September 2012 |
| Contact information |
Nicole Simunovic tel: 905‐527‐4322 ext 44695 email: simunon@mcmaster.ca |
| Notes |
|
